HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roy M Anderson Selected Research

Therapeutics

1/2020Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology.
1/2019Unsuccessful trials of therapies for Alzheimer's disease - Authors' reply.
1/2018Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections.
11/2017Why do so many clinical trials of therapies for Alzheimer's disease fail?
1/2017A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.
1/2016Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.
1/2016How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?
10/2006Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
4/2006Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.
7/2002Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roy M Anderson Research Topics

Disease

36Infections
12/2023 - 10/2005
8Schistosomiasis (Bilharziasis)
04/2024 - 01/2016
7Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2017
6Neglected Diseases
12/2021 - 01/2016
5Filarial Elephantiasis (Lymphatic Filariasis)
04/2024 - 01/2016
4Disease Progression
01/2020 - 04/2006
3COVID-19
03/2023 - 12/2021
3Virus Diseases (Viral Diseases)
12/2022 - 01/2016
3Onchocerciasis
01/2021 - 01/2016
3Trachoma
01/2021 - 01/2016
3Helminthiasis (Helminthiases)
11/2020 - 03/2015
3Hookworm Infections (Hookworm Infection)
11/2019 - 01/2016
2Cognitive Dysfunction
01/2020 - 07/2018
2Acquired Immunodeficiency Syndrome (AIDS)
04/2006 - 07/2002
2HIV Infections (HIV Infection)
06/2002 - 03/2002
1Flushing
06/2023
1Post-Acute COVID-19 Syndrome
03/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2022
1Breakthrough Infections
12/2021
1Pneumococcal Infections
11/2020
1Mixed Dementias
01/2020
1Atrophy
01/2020
1Reinfection
01/2019
1Dementia (Dementias)
01/2018
1Trichuriasis
01/2016
1Ascariasis
01/2016
1Human Influenza (Influenza)
02/2011
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
03/2007
1Myocardial Infarction
10/2006
1Infertility (Sterility)
03/2002

Drug/Important Bio-Agent (IBA)

9VaccinesIBA
03/2023 - 02/2011
4Praziquantel (Biltricide)FDA Link
02/2022 - 01/2020
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2017
3Albendazole (Albenza)FDA Link
12/2023 - 06/2016
3Antiviral Agents (Antivirals)IBA
12/2022 - 02/2011
3Amyloid (Amyloid Fibrils)IBA
01/2020 - 07/2018
2Indicators and Reagents (Reagents)IBA
01/2019 - 01/2018
2AnthelminticsIBA
01/2016 - 01/2016
1Aligeron (AS 2)IBA
12/2023
1Complement System Proteins (Complement)IBA
06/2023
1Nasal SpraysIBA
12/2022
1EpitopesIBA
12/2021
1AntigensIBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
06/2020
1Apolipoproteins E (ApoE)IBA
01/2018
1Mebendazole (Anti-Worm)FDA Link
06/2016
1RNA (Ribonucleic Acid)IBA
10/2005
1Contraceptive Agents (Contraceptives)IBA
03/2002

Therapy/Procedure

29Mass Drug Administration
04/2024 - 03/2015
11Drug Therapy (Chemotherapy)
04/2024 - 01/2016
10Therapeutics
01/2020 - 07/2002
2Bathroom Equipment
06/2023 - 11/2019
2Condoms (Condom)
03/2007 - 06/2002
1Immunotherapy
01/2016
1Chemoprevention
09/2007